Seventy-five years ago, Henrietta Lacks unknowingly contributed to a pivotal moment in medical history. In 1951, doctors at Johns Hopkins Hospital harvested cells from Lacks, an African American patient suffering from cervical cancer, without her consent. These cells, known as HeLa cells, would become fundamental to numerous medical breakthroughs, including the development of vaccines for polio and HPV, as well as treatments for HIV/AIDS, leukemia, and influenza. Despite passing away in 1951, Lacks’s legacy continues to influence scientific research and ethical standards in medicine today.
The ethical implications of Lacks’s story have gained renewed attention in light of recent legal developments. The descendants of Lacks filed a lawsuit against Thermo Fisher Scientific, asserting that the company profited significantly from a system that exploited marginalized communities. In 2023, they reached a confidential settlement, with another settlement involving Novartis finalized earlier this month.
The Impact of HeLa Cells on Research
Henrietta Lacks was born in 1920 in Roanoke, Virginia. After marrying David “Day” Lacks in 1941, they had five children. She first visited Johns Hopkins on February 1, 1951, seeking treatment for a “knot” in her cervix. Then a public hospital accessible to Black patients, Johns Hopkins had a troubling history of using patients for research without their knowledge. Following a biopsy, Lacks was diagnosed with cervical cancer and signed a consent form for necessary surgical procedures, unaware that samples from her tumor and healthy tissue would be taken for research.
Dr. George Gey, who cultured the cells in his lab, found that Lacks’s cancerous cells were not only surviving but replicating at an unprecedented rate. This discovery led to the creation of the first immortal human cell line, which was subsequently shared with researchers worldwide. Notably, Lacks was never acknowledged in these discussions, a fact that underscores the ethical breaches of the era.
Dr. Sabrina Assoumou, an infectious disease physician at Boston Medical Center, emphasizes the crucial role HeLa cells have played in her research on HIV. The understanding gained from HeLa cells has been instrumental in developing medications, including a long-acting HIV treatment known as Sunlenca, recently approved by the FDA. Assoumou highlights the importance of sharing these advancements with marginalized communities to ensure equitable access to medical innovations.
The implications of HeLa cells extend beyond HIV research. Dr. Cigall Kadoch, an associate professor at Dana-Farber Cancer Institute and Harvard Medical School, notes that advancements in gene sequencing have allowed for deeper insights into the genetic underpinnings of various cancers. “Cancer is not one disease, but a very diverse, heterogeneous collection of many different diseases,” Kadoch explains. However, she acknowledges the challenges of maintaining consistent cell lines across laboratories, as variations in culture conditions can lead to significant differences in HeLa cells.
Shaping Ethical Standards in Research
The legacy of Henrietta Lacks has prompted a critical reevaluation of ethical standards surrounding informed consent in medical research. Assoumou has contributed to initiatives aimed at educating medical interpreters about the historical context of medical mistrust, including cases like Lacks’s and the Tuskegee syphilis study. This course seeks to empower interpreters to advocate for patients who may not be proficient in English, fostering a more patient-centric approach to clinical trials.
Kadoch emphasizes the necessity of informed consent to ensure diversity among research participants. Understanding the genetic variations among different populations is vital in the fight against cancer. “We’ll do a better job for our worldly effort against cancer if we understand the heterogeneous repertoire of individuals that get these diseases,” she asserts.
As researchers continue to build on the legacy of HeLa cells, Kadoch encourages her colleagues to acknowledge the contributions of patients like Henrietta Lacks. “Know what you work with, and where it came from,” she advises, highlighting the importance of ethical practices in scientific research.
The story of Henrietta Lacks serves as a powerful reminder of the intersection between ethics and medical research. Her immortal cells not only transformed scientific inquiry but also sparked essential conversations about consent and equity in healthcare. As the medical community continues to evolve, Lacks’s legacy will undoubtedly influence the future of research ethics for generations to come.
